Report Description

United States pharmacovigilance market is anticipated to witness rapid growth during the forecast period owing to the increasing rate of new drug developments via clinical trials. The rising cases of Adverse Drug Reaction (ADR) has further raised question on the drug safety and efficacy. This is acting as a major growth driver for pharmacovigilance market in the country. Moreover, consumer health protection acts provided by the government are also contributing to the growth of United States pharmacovigilance market.

According to World Health Organization, pharmacovigilance is a process of detection, assessment, monitoring and prevention of adverse event related with drug related problems. It helps in finding new safety concerns and evaluating the already known risks. Pharmacovigilance helps in keeping a watch on the benefit risk balance of any drug. Any change in the benefit risk ratio will alter the safety profile of the drug.

United States pharmacovigilance market can be segmented based on clinical trial phase, method, service provider, end-user and region. Based on clinical trial phase, market is segmented into pre-clinical, phase 1, phase 2, phase 3, and phase 4. Among them, the phase 4 segment currently dominates the market in United States as they act as an additional drug safety measure for drugs undergoing clinical trial. The segment is further expected to register fastest growth during the forecast period.

Based on service provider, the United States pharmacovigilance market is categorized into in-house and contract outsourcing. Here, the contract outsourcing service provider is poised to undergo fastest growth and dominate the market until 2025 as it eliminates the risk of business overhead costs. Additionally, the service is increasingly being adopted by several healthcare companies operating in the United States.

Major companies operating in United States pharmacovigilance market include F. Hoffmann-La Roche & Co., Laboratory Corporation of America Holdings, IBM Corporation, United BioSource Corporation, BioClinica Inc, Novatis Corporation, ArisGlobal LLC, Cognizant , Accenture, Capgemini US LLC, iGATE Corporation and iMEDGlobal Corporation, among others. The companies are increasing their market share by carrying out extensive R&D activities to offer advanced products and services.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of United States pharmacovigilance market.
  • To forecast United States pharmacovigilance market based on clinical trial phase, method, service provider, end-user, company and regional distribution.
  • To identify drivers and challenges for United States pharmacovigilance market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in United States pharmacovigilance market.
  • To identify and analyze the profile of leading players operating in the United States pharmacovigilance market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service provider companies across the United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated United States pharmacovigilance market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Pharmacovigilance service provider companies, pharmaceutical companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to pharmacovigilance
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmacovigilance companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States pharmacovigilance market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Pharmacovigilance Market, By Clinical Trial Phase:
    • Pre-Clinical
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • United States Pharmacovigilance Market, By Method:
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Spontaneous Reporting
    • Cohort Event Monitoring
    • EHR Mining
  • United States Pharmacovigilance Market, By Service Provider:
    • In-House
    • Contract Outsourcing
  • United States Pharmacovigilance Market, By End-User:
    • Hospitals
    • Research Organizations
    • Industries
  • United States Pharmacovigilance Market, By Region:
    • North-East
    • Mid-West
    • South
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States pharmacovigilance market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Pharmacovigilance Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Pharmacovigilance Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1.     By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4)

6.2.2.     By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining)

6.2.3.     By Service Provider (In-House, Contract Outsourcing)

6.2.4.     By End User (Hospitals, Research Organizations, Industries)

6.2.5.     By Company (2019)

6.2.6.     By Region

6.3.  Market Attractiveness Index

7.    United State In-House Phase Pharmacovigilance Market Outlook

7.1.  Market Size & Forecast

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1.     By Clinical Trial Phase

7.2.2.     By Method

7.2.3.     By End User

7.3.  Market Attractiveness Index

8.    United States Contract Outsourcing Pharmacovigilance Market Outlook

8.1.  Market Size & Forecast

8.1.1. By Value

8.2.  Market Share & Forecast

8.2.1.     By Clinical Trial Phase

8.2.2.     By Method

8.2.3.     By End User

8.3.  Market Attractiveness Index

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Supply Chain Analysis

11.  Market Trends & Development

12.  Policy & Regulatory Landscape

13.  United States Economic Profile

14.  Competitive Landscape

14.1.              Competition Outlook (Top Companies)

14.1.1.  F. Hoffmann-La Roche & Co.

14.1.2.  Laboratory Corporation of America Holdings

14.1.3.  IBM Corporation

14.1.4.  United BioSource Corporation

14.1.5.  BioClinica Inc

14.1.6.  Novatis Corporation

14.1.7.  ArisGlobal LLC

14.1.8.  Cognizant

14.1.9.  Accenture

14.1.10.                Capgemini US LLC

14.1.11.                iGATE Corporation

14.1.12.                iMEDGlobal Corporation

15.  Strategic Recommendations

16.  About us & Disclaimer

 (Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

US Pharmacovigilance Market to Witness an Impressive CAGR until 2025

Jun, 2020

Increasing rate of drug development and rising cases of adverse drug reactions to drive United States pharmacovigilance market